Study of the Evolution Profile of the Renal Doppler in the Perioperative Hepathic Transplantation

NCT ID: NCT04682236

Last Updated: 2020-12-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-11-25

Study Completion Date

2022-05-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Liver transplantation is associated with a modification of the perfusion pressures of the abdominal organs (preoperative portal hypertension in connection with liver pathology, and normalization of the perfusion pressures during surgery). This abrupt change in the infusion regime is probably responsible for an alteration in renal function in some patients, and the identification of renal vascular profiles using Doppler could point to pathological profiles, which should be diagnosed early.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Renal Failure

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Acute Renal Failure Chronic renal failure Liver transplant Renal vascular profiles Intraoperative hemodynamic instability Acute tubular necrosis Renal doppler

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient of full age (≥18 years)
* Patient operated on at the HUS for a liver transplant, between July 1, 2019 and June 30, 2020.
* Patients having undergone an evaluation of hepatic and renal vascular profiles perioperatively.
* Patients hospitalized in the surgical intensive care unit after hepatic transplant surgery.
* Patient not having expressed, after information, the reuse of his data for the purposes of this research

Exclusion Criteria

* Patient who expressed his opposition to participating in the study
* Patient with suspected obstructive acute renal failure
* Stenosis of renal arteries known at the time
* End-stage renal disease on dialysis
* Impossibility of giving the subject informed information (difficulties in understanding the subject, etc.)
* Subject under safeguard of justice
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Strasbourg, France

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Julien POTTECHER, MD, PhD

Role: STUDY_DIRECTOR

Strasbourg University Hospitals - Anesthesia-intensive care unit

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Strasbourg University Hospitals - Anesthesia-intensive care unit

Strasbourg, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Julien POTTECHER, MD, PhD

Role: CONTACT

Phone: 33 3 88 12 70 95

Email: [email protected]

Saïd CHAYER, PhD, HDR

Role: CONTACT

Phone: 33 3 88 11 66 90

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Julien POTTECHER, MD, PhD

Role: primary

Saïd CHAYER, PhD, HDR

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

8059

Identifier Type: -

Identifier Source: org_study_id